drugset / Trial / NCT00002590

Combination Chemotherapy in Treating Children With Lymphoma

NCT00002590

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have lymphoma.

Timeline

Start
1994-07
Primary completion
2001-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule
Subject Etoposide Small molecule
Subject Methotrexate Small molecule
Subject Pegaspargase Protein / enzyme biologic
Background Cyclophosphamide Other / unclassified
Background Daunorubicin Small molecule
Background Doxorubicin Other / unclassified
Background Leucovorin Small molecule
Background Prednisone Other / unclassified
Background Thioguanine Small molecule
Background Vincristine Small molecule
Background filgrastim Protein / enzyme biologic

Indications